NOTE 11 - BUSINESS SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2025

Notes

NOTE 11 - BUSINESS SEGMENT INFORMATION

NOTE 11 – BUSINESS SEGMENT INFORMATION

As of September 30, 2025, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the nine months ended September 30, 2025.

	CONSOLIDATED	HEALTH SUPPLEMENTS		CORPORATE
		BergaMet	UBN
Revenue	2,817,910	2,817,910	-	-
Cost of Revenue	1,352,848	1,352,848	-	-
Long-lived Assets	715,141	212,414	502,727	-
Gain (Loss) Before Income Tax	(727,133)	8,140	(300)	(734,973)
Identifiable Assets	966,522	966,522	-	-
Depreciation and Amortization	1,329	1,329	-	-

As of September 30, 2024, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the nine months ended September 30, 2024.

	CONSOLIDATED	HEALTH SUPPLEMENTS		CORPORATE
		BergaMet	UBN
Revenue	2,342,091	2,342,091	-	-
Cost of Revenue	845,185	845,185	-	-
Long-lived Assets	732,030	193,260	538,771	-
Gain (Loss) Before Income Tax	(393,742)	364,817	(770)	(757,789)
Identifiable Assets	1,443,505	1,443,505	-	-
Depreciation and Amortization	343	343	-	-

Currently, all of our customers are located in the United States of American and Canada. Our revenues to our customers are not material to our overall total sales. Our largest customers, Natural Grocers and Emerson Ecologics, LLC, account for less than 1% of our total sales in the nine months ending September 30, 2025 and 2024.